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Background: Different non-invasive real-time imaging techniques have been developed over the last decades to
study bacterial pathogenic mechanisms in mouse models by following infections over a time course. In vivo
investigations of bacterial infections previously relied mostly on bioluminescence imaging (BLI), which is able to
localize metabolically active bacteria, but provides no data on the status of the involved organs in the infected host
organism. In this study we established an in vivo imaging platform by magnetic resonance imaging (MRI) for
tracking bacteria in mouse models of infection to study infection biology of clinically relevant bacteria.
Results: We have developed a method to label Gram-positive and Gram-negative bacteria with iron oxide nano
particles and detected and pursued these with MRI. The key step for successful labeling was to manipulate the
bacterial surface charge by producing electro-competent cells enabling charge interactions between the iron
particles and the cell wall. Different particle sizes and coatings were tested for their ability to attach to the cell wall
and possible labeling mechanisms were elaborated by comparing Gram-positive and -negative bacterial
characteristics. With 5-nm citrate-coated particles an iron load of 0.015 ± 0.002 pg Fe/bacterial cell was achieved for
Staphylococcus aureus. In both a subcutaneous and a systemic infection model induced by iron-labeled S. aureus
bacteria, high resolution MR images allowed for bacterial tracking and provided information on the morphology of
organs and the inflammatory response.
Conclusion: Labeled with iron oxide particles, in vivo detection of small S. aureus colonies in infection models is
feasible by MRI and provides a versatile tool to follow bacterial infections in vivo. The established cell labeling
strategy can easily be transferred to other bacterial species and thus provides a conceptual advance in the field of
molecular MRI.
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Bacterial infections remain one of the major challenges
to human societies around the world. In particular, the
emergence of multiple antibiotic resistant bacteria,
which are difficult to treat and which can spread locally
and systemically in different organs within the infected
host, requires novel approaches for rapid diagnosis and
efficient treatment [1-3]. Also, a deeper understanding* Correspondence: faberc@uni-muenster.de
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reproduction in any medium, provided the orof pathogen biology as well as of the complex host-
pathogen interactions between bacteria and host tissues
are urgently required to improve antimicrobial strategies.
Staphylococcus aureus is a clinically highly relevant hu-
man pathogen, which has the potential to infect almost
every organ leading to a number of diverse infections
[4], such as skin and wound infections, pneumonia,
endocarditis and osteomyelitis [5,6]. S. aureus induces a
strong immune response either via a plethora of toxins
and superantigens [7], complement activation, or by
activation of the inflammasome and the related sterile
injury danger signal pathways. Yet, the dynamics oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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establish metastasizing infections in different organs
are largely unknown.
For research on dissemination dynamics in the entire
host organism, murine models of bacterial infections are
pivotal. Non-invasive in vivo imaging techniques, such
as magnetic resonance imaging (MRI), computed tomog-
raphy (CT), fluorescence/bioluminescence imaging (BLI)
or positron emission tomography (PET), have been
employed to visualize infections over the time course
[8-12]. Although different strategies for specific detec-
tion of bacteria have been developed [13-15], most im-
aging studies target host factors [16] or detect immune
cells [17]. Due to its high spatial resolution and excellent
soft tissue contrast, especially MRI is a versatile method
to image inflammatory processes upon bacterial infec-
tions non-invasively. While native MRI provides diag-
nostic information on tissue structures and the
inflammatory status [18], detection of distinct cellular
populations requires labeling with a suitable contrast
agent, such as iron oxide particles [19,20]. Cell labeling
and tracking experiments are commonly performed
either by labeling immune cells in vitro and regrafting
them or by systemic application of iron oxide particles
which are then phagocytosed by macrophages [21]. By
using negative iron contrast immunological reactions
and bacteria-induced inflammatory dissemination have
already been investigated in animal models of Staphylo-
coccus aureus [22-26], Toxoplasma gondii [27], Myco-
bacterium tuberculosis [28] or LPS-induced sepsis
conditions [29,30]. However, only BLI so far was cap-
able of visualizing bacteria directly. This technique
exploits detection of light emitted from luminescent
proteins in transgenic and metabolically active bacteria.
Owing to this unique property, BLI has become the
most important and wide spread modality of detecting
bacteria in vivo [31]. Here, we propose a complemen-
tary imaging modality based on MRI that requires the
application of pre-treated bacteria, but which is also
suitable for metabolically inactive or anaerobic patho-
gens and which provides detailed information about
the bacterial localization in tissue. While native MRI
provides diagnostic information on tissue structures
and the inflammatory status, detection of distinct cellular
populations requires labeling with a suitable contrast agent.
We have used bimodal iron oxide nano particles (IONPs)
to detect bacteria and have monitored dissemination in
mouse models of local and systemic S. aureus infection.
While for eukaryotic cells a variety of labeling protocols for
cell imaging have been established, bacteria require specific
labeling procedures that account for the presence of the
bacterial cell wall. We have implemented a protocol that
affords stable labeling of S. aureus cells with rhodamine-
labeled 5-nm citrate-coated IONPs.Results and discussion
Labeling strategy
Depending on the phagocytotic cell characteristics,
eukaryotic cells are commonly labeled either by incuba-
tion, transfection or electroporation [21]. To establish a
labeling protocol for bacteria with MRI-sensitive con-
trast agents, we applied different labeling strategies and
(1) electroporated electro-competent bacterial cells, (2)
incubated electro-competent bacterial cells or (3) in-
cubated unmodified bacterial cells with iron oxide
particles of different size and coating. Labeling effi-
ciency was assessed by confocal fluorescence microscopy
using rhodamine-labeled particles and Syto 9 for
co-registration (Figure 1). Syto 9 is a DNA marker and
generally labels all bacteria in a population with a green
fluorescence [32,33]. Our results showed that the pivotal
step was to manipulate the structure of the cell wall
by preparing electro-competent cells (Figure 1A-C).
Electroporation of electro-competent S. aureus bacteria in
the presence of 5-nm citrate-coated IONPs, according to
BIO-RAD standard protocols [34,35], produced iron-
labeled bacteria (Figure 1A). However, the procedure
resulted in 47 ± 22% cell death, visible as iron-labeled cell
debris by electron microscopy (Figure 1E) and precluded
the method as labeling strategy for imaging experiments.
On the other hand, when unmodified cells were simply in-
cubated with IONPs, no fluorescence signal was detectable
(Figure 1B). In contrast, after simple incubation of compe-
tent S. aureus bacteria with iron particles the rhodamine
fluorescence signal was observable at the cell surface
(Figure 1C). Compared to untreated cells the iron-labeled
cell population showed the same natural cell death.
Electron microscopy confirmed that clusters of IONPs
were bound to the proteoglycane matrix that surrounds
the cell (Figure 1F). An iron concentration of 1 μmol Fe
per ml and 108 bacteria was required to achieve sound
labeling. By atomic spectrometry the iron load per cell was
determined as 0.015 ± 0.002 pg Fe.
Larger particles or particles with other surface proper-
ties did not result in a homogeneous labeling of the
cells, as shown by fluorescence microscopy (Figure 1D,
Additional file 1). All studied 100-nm IONPs, independ-
ent from coating and surface charge, formed large par-
ticle aggregates which were attached to sporadic cells
(see Additional file 1). When electro-competent S. aur-
eus bacteria were incubated with 5-nm particles, only
particles with citrate-coating led to a uniform iron la-
beling, while amine-coated particles labeled the cell sus-
pension very inhomogeneously and resulted in scattered
red fluorescent bacteria (Figure 1C, D). In contrast, for
Gram-negative E. coli bacteria good labeling results were
achieved both for citrate- and amine-coated IONPs lead-
ing to a labeling efficiency of 0.024 ± 0.003 pg/cell and
0.060 ± 0.004 pg/cell respectively (see Additional file 2).
Figure 1 Validation of bacterial cell labeling with iron oxide particles. Fluorescence microscopy of S. aureus bacteria (strain 6850) labeled
with Syto 9 (green) and rhodamine-labeled 5-nm citrate-coated iron oxide nano particles (IONPs) (red) using different labeling strategies: (A)
electroporation of electro-competent bacterial cells, (B) incubation of unmodified bacterial cells and (C) incubation of electro-competent bacterial
cells. Syto 9 was used for co-registration. (D) S. aureus bacteria labeled with 5-nm amine-coated IONPs by incubation of electro-competent
bacterial cells. Electron microscopy images of S. aureus bacterial cell samples labeled by (E) electroporation and (F) incubation show a high
percentage of cell debris when the electroporation technique was used (yellow arrowheads in (E)) and clusters of IONPs bound to the surface of
intact bacteria (yellow arrows in (F)).
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ened cell wall with pores in the structure [36,37] and a
much more homogeneous distribution of positively and
negatively charged ions on the peptidoglycan matrix,
providing an enlarged surface for interactions between
charged iron particles and the cell wall. In Gram-
positive S. aureus bacteria the cell wall mainly consists
of a thick peptidoglycan layer giving rise to a positive
net charge which may explain the high labeling effi-
ciency when citrate-coated iron particles were used. In
contrast, in Gram-negative E. coli bacteria the negatively
charged lipopolysaccharide outer membrane leaf [38],
which envelopes the cell, may explain the good labeling
results for amine-coated IONPs.In vitro assays
To exclude a possible influence of the labeling procedure
on bacterial cell characteristics we investigated growth
behavior as well as cytotoxicity and invasion of iron-
labeled bacteria. Growth curves did not differ signifi-
cantly between untreated cells, and competent cells either
with or without iron incubation (Figure 2A). Furthermore,
infection models in HUVECs did not reveal differences
between iron-labeled and unlabeled bacteria regarding
cytotoxicity (Figure 2C) and invasive capacity (Figure 2D).
Most iron oxide particles have the formula Fe2
3+O3Fe
2+O,
embedding the bi- and trivalent iron ions in a crystalline
structure, which is chemically protected by molecular
coatings. In our labeling procedure the iron particles
Figure 2 In vitro assays of iron-labeled S. aureus bacteria on HUVEC cells and macrophages. Iron-labeled and non-labeled S. aureus
bacteria (strain 6850) were compared to each other with regards to growth behavior, their cytotoxicity and invasiveness in HUVEC cells as well as
their phagocytosis by macrophages. (A) In growth curves of S. aureus wild type cells (6850 wt) and electro-competent cells with (6850 comp cells
w /iron) and without (6850 comp cell) iron particles, no significant differences were observed for the three cell cultures. (B) The fluorescence
microscopic image shows how iron-labeled bacteria are phagocytized by macrophages. (C) In the cytotoxicity assay, cell death of HUVEC cells
was compared and quantified upon treatment with S. aureus wild type cells, electro-competent and iron labeled bacteria. (D) In the invasion
assay the invasiveness of the laboratory strain Cowan I was set as 100%, the non-invasive laboratory strain TM300 was used as a negative control.
Neither growth behavior, cytotoxicity, invasiveness nor phagocytosis by macrophages was affected by the iron label.
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by the bacteria. This approach avoids bactericidal iron ions
entering the bacteria, which may otherwise lead to toxic
effects as described for iron complexes [39].
One of the most important types of immune cells recog-
nizing invading bacteria in vivo, are macrophages. There-
fore, we investigated in in vitro experiments whether
bacteria carrying iron particles can still induce phagocy-
totic responses of macrophages. After adding iron-labeled
bacteria to a suspension of murine macrophages, live
microscopy showed that macrophages immediately started
phagocytizing the labeled bacteria (Figure 2B, Additional
file 3). These data show that iron labeling does not
abrogate phagocytosis.
Binding stability
For the use of MRI to detect and track bacteria in ani-
mal models, it is of the utmost importance that the labelis conserved over time and bacteria remain detectable
after several growth cycles. Electron microscopy showed
that IONPs remained bound to the surface after cell
division and were passed on to the daughter cells
(Figure 1F). Thus, each cell division step continuously
led to a dilution of IONPs. To determine how fast
the iron on the cell wall is diluted during cell growth
and to estimate the minimum iron concentration that
is detectable by MRI, growth curves of labeled bac-
teria were measured using an initial inoculum of an OD
(optical density) value of 0.5. Every hour OD values and
CFU (colony forming units) counts were determined and
corresponding T1 (longitudinal relaxation time) and T2
(transverse relaxation time) values were measured at 9.4 T
from a sample diluted to the initial cell concentration of
0.5 OD. Prior to MRI measurements the corresponding
cell samples were separated from the medium and were
embedded in 500 μl of 0.5% agarose. While T1 did not
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cantly decreased at the beginning of the growth curve and
increased steadily until a stationary value was reached
after 3 h (Figure 3A, B, Additional file 4). According to
the OD values and CFU counts, the cell density increased
35-fold during the first 3 h which resulted in a cell con-
centration of 2.3 × 109 cells/ml. This observation con-
firmed that the binding of IONPs to the cell surface is
stable and can be detected at least over five cycles of cell
division. To assess the sensitivity and reliability of detec-
tion, we reversed the culture experiment and measured
T2 of bacteria cultures labeled with a serial two-fold dilu-
tion of IONPs (Figure 3C). The corresponding T2 values
indicated that bacteria were labeled to saturation for the
initial dilution steps. From the third dilution on, T2 in-
creased continuously with decreasing amount of iron. The
T2 relaxation times measured after different cell division
cycles (Figure 3B) correlated well with those obtained
from cells labeled with different iron dilutions. T2 relax-
ation times of 121 ms and 142 ms, which were measured
with a 1:8 and 1:32 iron dilution were also obtained from
the growth curve at 1.2 h and 3 h, perfectly corresponding
to three and five cell divisions.
In vivo mouse models
For mammalian cells it has been shown previously that
very low cell numbers, down to a single cell, can be
detected and tracked by MRI [40]. Due to the very small
size of bacteria (0.5 to 1 μm diameter) and the different
labeling procedure, the feasibility of detection as well as
its limits had to be assessed. To this end a local skin in-
fection was induced by subcutaneous administration of
either IONP-labeled or unlabeled S. aureus in the left
flank of the mice. Formation of an ulcer 24 h post infec-
tion was obvious in MR images, showing the resultingFigure 3 Iron dilution during cell growth determined by MRI. (A) Cell
samples at different time points of the growth curve. Cell cultures were lab
MRI measurements bacterial samples at each time point were diluted to an
0.5% agarose. (C) T2 measurements of agarose embedded cell cultures l
μmol Fe/ml, 0.5 μmol Fe/ml, 0.25 μmol Fe/ml, 0.125 μmol Fe/ml, 0.063 μ
of the initial iron concentration imitate the iron dilution caused by cell d
measurement at 3 h in (B).edema as extended hyperintensity (Figure 4A). S. aureus
colonies were identified as clearly circumscribed hypo-
intensities in T2*-weighted images (Figure 4A). While
T2*-weighting enhances the size of the actual colony,
UTE (ultra-short echo time) MRI was able to visualize
the extent of the colony more exactly (Figure 4B). How-
ever, for lower numbers of bacteria the blooming effect
of T2*-weighting was required to detect the bacteria.
The MRI detection limit of bacteria was assessed by
infections with different numbers of labeled bacteria
(104, 105, 106, 107 CFUs) (Figure 4D-G). A circum-
scribed hypointensity within the zone of inflammation
was still reliably detectable in T2*-weighted images for
105 bacteria CFUs, the same order of magnitude as
found for BLI and fluorescence imaging [13]. Electron
microscopy and Prussian blue staining of tissue sections
24 h post infection confirmed that IONPs were still
bound to the cell surface giving rise to the observed
hypointensities. Iron staining reproduced clusters of
coccal-shaped bacteria observed in Gram stained sec-
tions of the inflamed tissue (Figure 4H-J). One of the
big challenges in molecular MRI is to quantify the
negative contrast caused by iron particles. Most studies
have therefore focused on the qualitative assessment of
hyper- and hypointense tissue contrast. Only few ap-
proaches have so far quantitatively tracked iron labeled
cells, using, for example, shifted spin echo ultrashort
T2* [41] or quantitative susceptibility mapping [42]. In
our study, to quantify the amount of iron particles which
is still bound on living bacteria 24 h post infection, we
determined the iron concentration of bacterial colonies
recovered from infected tissue on agar plates. From 107
cells, which were injected subcutaneously to induce the
infection, 3.92 × 106 ± 3.18 × 106 cells/ml per g tissue
were recovered after 24 h, providing an iron content ofdensity and (B) transverse relaxation time (T2) of iron-labeled S. aureus
eled with 5-nm citrate coated IONPs (1 μmol Fe/ml for 108 cells). For
initial cell concentration of OD 0.5 and were embedded in 500 μl
abeled with different iron concentrations in a 1:2 dilution row: 1
mol Fe/ml, 0.031 μmol Fe/ml, 0.016 μmol Fe/ml. 1:2 dilution steps
ivision cycles. Note that dilution step 5 in (C) corresponds with
Figure 4 (See legend on next page.)
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Figure 4 MR images of a subcutaneous infection induced by iron-labeled bacteria investigated 24 h post infection. Axial T2*-weighted
(A) and UTE (B) images of the mouse flank, revealing an ulcerous abscess (red circle) with bacterial colonization (yellow arrows). (C) Axial T2*-
weighted MRI of the subcutaneous infection with unlabeled bacteria, following intravenous co-injection of 5-nm IONP 2 h and 5 h post infection.
(D-G) Axial T2*-weighted MRI of the mouse flank revealing an ulcerous abscess (red circle) with bacterial colonization (yellow arrows). The local
skin infection was induced by different numbers of iron-labeled bacteria (D) 107 CFU, (E) 106 CFU, (F) 105 CFU, (G) 104 CFU. Bacteria were
observed as hypointensities (yellow arrow) when iron-labeled S. aureus at a number ≥105 CFU were applied. (H) Electron microscopy, (I) Prussian
blue staining and (J) Gram staining of tissue sections of the inflammatory lesion showing iron-labeled bacteria. (K) CFU counts after magnetic
separation of homogenized tissue infected with either iron-labeled or non-labeled S. aureus bacteria. (L and M) Fluorescence microscopy of
homogenized infected tissue visualized in the green (1), red (2) and merged (3) fluorescence channel. Either unlabeled (L) S. aureus bacteria or
bacteria labeled with rhodamine-coated IONPs (red, M) were used to induce the infection. For co-registration all bacteria were labeled with Syto
9 (green). (N) Gram (N1) and Prussian blue (N2) staining of homogenized tissue infected with iron-labeled bacteria. (O) Immunohistology of S.
aureus infected skin tissue showing intracellular (yellow arrowhead, O1) and extracellular (O2) bacteria. Bacteria are stained green, macrophages
red and nuclei blue. (P and Q) Hematoxylin/Eosin (P) and Prussian blue (Q) staining of tissue section of a lesion after subcutaneous infection with
unlabeled S. aureus, followed by intravenous co-injection of 5-nm IONP 2 h and 5 h post infection. (R) Prussian blue staining of inflamed tissue
with macrophage invasion, after infection with iron-labeled S. aureus bacteria.
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tration of 0.0020 ± 0.0016 pg Fe per cell. Compared to
the initial labeling efficiency of 0.015 ± 0.002 pg Fe, the
iron concentration per cell is approximately diluted
10-fold. By magnetic separation, which acts on bacteria
that carry the iron label, 5.4 ± 4.8% of the recovered
bacteria population could be separated from homoge-
nized tissue (Figure 4K). However, the extracted bacterial
number strongly depended on the iron distribution on
single bacteria and bacterial clusters and, thus, repre-
sents only a rough estimation with pronounced variation
between different tissue samples. After staining the re-
covered cell suspensions with Syto 9, the red fluores-
cence of the iron particles was co-localized with the
detected bacteria (Figure 4M1-M3), confirming that the
iron was still bound to the bacteria. The presence of in-
tact bacteria in the tissue homogenate was confirmed by
Gram and iron staining (Figure 4N1, N2). To assess the
fraction of phagocytosed bacteria, 24 h post infection,
tissue sections were stained with macrophage and
S. aureus-specific antibodies. Intra- and extracellular
bacteria were counted and averaged over 20 sections.
Only a small fraction of 10% of the total bacterial num-
ber was observed intracellularly (yellow arrowhead,
Figure 4O1, O2).
The particular strength of MRI for bacterial detection
lies in its independence from metabolic activity and
oxygenic environment, making it possible to also follow
intracellular metabolically inactive S. aureus, such as the
clinically highly relevant small colony variants [43,44].
For many bacterial pathogens and particularly for S. aureus,
the intracellular persistence is increasingly recognized
as an important infection and immune evasion strategy
that causes chronic and therapy-refractory infections [45].
It has been demonstrated that S. aureus can invade and
survive in different cell types, including professional
phagocytes [46]. The use of iron labeled bacteria allowed
us to track the surviving bacterial population in macro-
phages. Iron of digested bacteria is also distributed byimmune cells over the time course, but these give rise to a
different MRI pattern. Macrophage labeling by i.v. in-
jection of IONPs 2 h and 5 h post infection resulted in
a circumferential dark pattern at the border of the
inflammation (Figure 4C) without clear hypointensities
that indicated bacterial colonies. Histologically, large,
not circumscribed areas of distributed iron were
detected in zones of intense macrophage invasion
(Figure 4P, Q). By contrast, after infection with iron
labeled bacteria only sparely distributed single macro-
phages were labeled with Prussian blue (Figure 4R).
The feasibility to track S. aureus in vivo was demon-
strated in a footpad infection model which regularly
involves draining lymph nodes [47]. IONP-labeled S.
aureus (2 × 107 CFU) were injected into the footpad,
causing an inflammatory reaction (Figure 5). Similar to
the local infection model, labeled bacteria were detected
at the site of injection (Figure 6A, B). Beyond that, dis-
tant from the injection site, 1 d and 3 d after infection
labeled bacteria were observed as hypointensities in the
popliteal lymph node of the infected leg (Figure 6C). In
contrast, lymph nodes of the infected leg after injection
of unlabeled bacteria showed swelling as a sign of a
systemic infection, but no typical hypointensities
(Figure 6D). Popliteal lymph nodes of the uninfected leg
did not show signs of inflammation and lymph nodes of
mice being injected with iron particles only, did not
show hypointensities (see Additional file 5). Electron
microscopy, Gram and Prussian blue staining of tissue
sections confirmed the presence of iron-labeled bacteria
in the contrasted lymph nodes (Figure 6E-H). These data
show that disseminating bacteria are detectable by MRI.
Even though BLI is a well-established method of study-
ing bacterial infections in animal models and is superior
to MRI with regards to ease of use, cost and scan time,
it is strictly limited to preclinical studies. MRI on the
other hand is directly amenable to study human sub-
jects. Our MRI approach to track bacteria in vivo, raises
hope that this modality can be transferred into the
Figure 5 Footpad infection model induced by unlabeled and
iron-labeled S. aureus bacteria. (A) Time course of footpad
swelling and (B) bacterial load in infected footpads and draining
popliteal and inguinal lymph nodes at three days after infection.
Hoerr et al. BMC Biology 2013, 11:63 Page 8 of 13
http://www.biomedcentral.com/1741-7007/11/63clinics in the future, when pathogen-specific contrast
agents have become available.
Conclusions
In conclusion, we have established a novel modality for
in vivo detection and tracking of bacteria, which is com-
plementary to BLI. With the application of pre-labeled
bacteria, the method is limited to use in animal models,
as is BLI. The great advantage of MRI is the simultan-
eous imaging of morphology, organ compartments and
immune response together with the data on bacterial
tracking. Additionally, MRI detection is also applicable
to metabolically less active as well as anaerobic bacteria
and not subject to limited penetration depth. Therefore,
we are confident that this modality greatly enhances the
diagnostic and analytical options in fundamental and
translational research on bacterial infections.
Methods
Bacteria and growth conditions
Bacterial strains
Experiments were performed with the two S. aureus
bacterial strains, 6850 (ATCC 53657) [48] and SH1000[49] which is a derivate of strain 8325–4 with restored
rsbUþ-gene. As a Gram-negative strain E. coli K12 was
used.
Cultivation
Bacteria were cultured in Mueller-Hinton (MH, S. aureus)
or Luria Bertani (LB, E. coli) medium overnight at 37°C
with shaking at 160 rpm and were subsequently used to
prepare electro-competent cells or to perform in vitro
assays.
Bacterial concentration
The cell concentration was determined by measuring
the OD578 (optical density at 578 nm) spectroscopically
and by counting the colony forming units (CFU). A bac-
terial sample was serially diluted and a known volume
was plated on blood agar. The bacterial concentration
was obtained by counting the number of colonies that
had formed.
Electro-competent bacteria
Electro-competent S. aureus and E. coli bacteria were
made according to the manufacturer’s protocol sug-
gested for each microorganism [35] and were frozen in
10% glycerol in a concentration of 109 to 1010 cells/ml.
Labeling bacteria
To label bacteria, either electro-competent or naïve cells
were used. A total of 50 μl of the cell suspension was in-
cubated with 2 μl of iron oxide particles in 950 μl MH
or LB medium for 1 h at 37°C and 160 rpm. The follow-
ing IONPs were used: VSOP-rhodamine 5 nm and
VSOP-link-rhodamine 5 nm (Very Small Iron Oxide
Particles, both Ferropharm AG, Teltow, Germany),
screenMAG 100 nm (diethylamine ethyl, phosphatidyl-
cholin and poly(maleic acid-co-olefin), polysaccharide,
all Chemicell, Berlin, Germany). VSOP particles consist
of a 5 nm maghemit core and hold an iron concentra-
tion of approximately 2.2 × 10-19 g/per particle. Prior to
use, cell suspensions were centrifuged at 5,000 rpm for
10 minutes to remove culture media as well as excessive
IONPs and pellets were washed once with phosphate-
buffered saline (PBS) and were resuspended in PBS. La-
beling efficiency was visualized by fluorescence micros-
copy and bacteria were additionally labeled with Syto 9
(Invitrogen, Darmstadt, Germany) for co-registration
according to molecular probes standard protocols.
Lysostaphin protection assay
The invasiveness of S. aureus with or without iron label-
ing in endothelial cells was performed by lysostaphin
protection assay. Two days prior to the assay 1 ml
HUVEC (2 × 105 cells/ml) was plated in 12-well plates
in M199 medium (PAA Laboratories GmbH, Cölbe,
Figure 6 MR images of a footpad infection induced by iron-labeled S. aureus bacteria. Axial T2*-weighted MRI of the inflamed left footpad
induced with (A) and without (B) iron-labeled bacteria, 24 h post infection. Bacteria were observed as hypointensities in the footpad (yellow
arrow) when iron-labeled S. aureus were applied. (C, D) T2-weighted MRI of inflamed lymph nodes, Day 1 and Day 3 post infection. Bacteria were
observed as hypointensities in the lymph nodes (yellow arrow) when iron-labeled S. aureus were applied. Electron microscopy (E, F), Prussian blue
staining (G) and Gram staining (H) of the lymph node, 24 h post infection, showing iron-labeled bacteria.
Hoerr et al. BMC Biology 2013, 11:63 Page 9 of 13
http://www.biomedcentral.com/1741-7007/11/63Germany) and was stimulated with live bacteria. Bacteria
from frozen stock suspensions were washed once with
PBS and adjusted to a cell concentration of 5 × 108
cells/ml in MH medium and were incubated for 1 h at
37°C and 160 rpm. When the assay was performed with
iron-labeled bacteria, freshly prepared cultures according
to the labeling protocol were used directly. Bacteria were
harvested, washed once and resuspended in PBS. A total
of 100 μl of the bacterial suspensions were added to each
well. After an invasion period of 3 h, HUVEC were
washed with PBS, the culture medium was replaced by
M199 plus 10% FCS (fetal calf serum) and the HUVEC
were incubated with lysostaphin (20 μg/ml) for 30 mi-
nutes at 37°C in order to remove extracellular staphylo-
cocci. The cells were washed with PBS and intracellular
bacteria were released by incubation in 1 ml of H2O for
30 minutes at 37°C. Samples were diluted in PBS and
plated on blood agar plates to determine the number of
recovered CFUs. The assay was performed with a posi-
tive (Cowan I) and a negative control (TM300). The
invasiveness of the laboratory strain Cowan I was set as
100%.Cell death assays
Analysis of cell death was performed by measuring the
proportion of hypodiploid nuclei as described in
Haslinger-Löffler et al. [50]. Briefly, HUVEC plated in
12-well plates were incubated for 3 h with 20 μl of 5 ×
108 CFU/ml S. aureus bacteria per well. Incubation withlysostaphin for 30 minutes followed. After the removal
of extracellular staphylococci, HUVEC were washed with
PBS and full medium was added. After 20 h the cell
death was determined and cells were stained with the
DNA-dye propidium iodide and analyzed with a FACS
Calibur flow cytometer (Becton Dickinson, Heidelberg,
Germany).Growth curve assay
In a 500 ml flask, 50 ml of bacterial staphylococcal cell
suspension with an initial cell concentration of OD 0.5
was incubated for 7 h at 37°C and 160 rpm in MH
medium. Every hour a sample was taken to measure OD
and CFU counts/ml.Bacteria recovered from infected tissue
Approximately 0.1 g infected skin tissue was collected
and homogenized in 2 ml PBS. An aliquot of 100 μl was
plated on blood agar over night and the CFUs harvested
and suspended in 1 ml PBS. The iron concentration of
the cell suspension was subsequently measured by
atomic spectrometry. To determine the iron concentra-
tion per cell the measured iron content was corrected by
an iron baseline. Since iron is an important nutrient in
agar plates, it is taken up during cell growth. As a base-
line a defined number of S. aureus bacteria were cul-
tured on blood agar plates, harvested, suspended in 1 ml
PBS and measured by atomic spectrometry.
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The number of iron labeled bacteria in infected tissue
was determined with the aid of magnetic separation. For
this purpose, 1 ml tissue sample was placed in a mag-
netic field for five minutes, washed twice with PBS,
diluted with 1 ml PBS and plated for CFU count. CFU
counts of iron-labeled and unlabeled bacteria were
analyzed by a Mann–Whitney-Test.Fluorescence microscopy
Labeled bacteria suspensions were added with 0.1%
agarose and sealed by a second coverslip. Fluorescence
images were obtained with a commercial 4Pi microscope
(TCS 4Pi microscope type A, Leica Microsystems
GmbH, Wetzlar, Germany) employing oil immersion
lenses (×100, numerical aperture 1.46). The TCS 4Pi is a
confocal laser scanning microscope of type TCS SP2 in-
corporating single as well as two-photon excitation,
photon-counting by avalanche photodiodes, and a 4Pi
attachment. Because of these features the microscope
could be employed in the confocal mode with upright or
inverted beam path and single- or two-photon excita-
tion, or as a two-photon excitation 4Pi microscope. The
images were taken in the confocal mode of the micro-
scope. Due to the spherical shape of the S. aureus bac-
teria the 4Pi mode brings no significant gain in
resolution. In a 4Pi image, every pixel has attached an
interference function in z direction. If we take a picture
of a sphere, these functions strongly overlap and cause
blurring. Single-photon excitation wavelengths of 476
and 561 nm was used, yielding best case resolutions of
166 nm and 196 nm, respectively, in both x and y direc-
tion. The beam expander was set to 6. Fluorescence
originating from the sample was passed through a filter
cube (short-pass 700 nm, beam splitter 560 nm, band-
pass 500 to 550 nm, and band-pass 607 to 683 nm), and
its intensity was measured by photon-counting ava-
lanche photodiodes (PerkinElmer, Waltham, MA, USA).
The detection pinhole was set to 1 Airy unit. Images of
the cells were recorded with a pixel size between 12 × 12
nm2 and 42 × 42 nm2. Raw images were linearly bright-
ened, rescaled and linearly filtered by a subresolution
mask using the image processing program ImageJ (Wayne
Rasband, US National Institutes of Health, [51]).Live cell microscopy
Bone marrow-derived macrophages (BMDMs) were
differentiated in vitro from bone marrow as previously
described [52]. BMDMs were transferred to fibronectin-
coated LabTek chamber slides and incubated for at least
12 h to achieve adherence. After that, live bacteria were
added (MOI 50) and life cell imaging was performed
using an inverted fluorescence microscope (Zeizz AxioObserver Z1; Carl Zeiss MicroImaging GmbH, Jena,
Germany; 40× objective magnification).
Histology
For histopathology, cryo and paraffin sections of lymph
node and skin tissue were prepared and Gram-positive
bacteria were stained with crystal violet/iodine and Prus-
sian blue according to standard protocols. Macrophages
were stained with hematoxylin and eosin. Bacteria and
macrophages were visualized using a light microscope
(Zeiss Axioskop, Goettingen, Germany; 100×, 40×, 20×
10× objective magnification).
Immunohistology
For immunohistology, paraffin embedded sections of
infected skin tissue (5 μm) were prepared on slides and
blocked with 2% BSA. Macrophages and S. aureus bac-
teria were stained according to standard protocols using
an appropriate dilution of a monoclonal rat anti-mouse
F4/80 antibody (clone BM8, purchased from Biolegend,
Fell, Germany) or a polyclonal rabbit anti-S. aureus IgG
(Abcam, Cambridge, UK) followed by incubation with
AlexaFluor 568-conjugated anti-rat and AlexaFluor 488-
conjugated anti-rabbit secondary antibodies (both pur-
chased from Invitrogen, Karlsruhe, Germany). Nuclei
were counterstained using 0.1 μg/ml 4′,6-diamidino-2-
phenylindole (DAPI). Macrophages and S. aureus bac-
teria were visualized by fluorescence microscopy using
an Olympus BX63 microscope and the CellSens Soft-
ware (Olympus, Münster, Germany). Immunofluores-
cence staining is depicted in an original magnification of
100×.
Electron microscopy
Mice were sacrificed and intravenously perfused with
modified Karnovsky’s fixative consisting of 2.5% glutaral-
dehyde, 2% paraformaldehyde in PBS. After fixation of
the infected organ or tissue, samples were dissected and
placed in fresh fixative and kept overnight at 4°C. Subse-
quently, tissue was washed three times with 0.1 M
cacodylat buffer for 5 to 10 minutes, cut into pieces ≤1
mm and post-fixed with 2% osmium tetroxide at room
temperature for 1 h. The samples were extensively
washed with 0.1 M cacodylat buffer and stained with
1.5% uranyl acetate for 1 h during dehydration in an
ethanol series. In the last dehydration step after pure
ethanol pure acetone was used. Tissue samples were
then embedded in Epon 812. Ultrathin sections (<60
nm) were collected on Formvar coated copper grids and
viewed with a Phillips CM 10 or Zeiss Libra 120 (Zeiss,
Oberkochen, Germany) electron microscope.
Iron-labeled bacteria samples were embedded in 1%
agarose and then fixed for more than 24 h using the
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aration steps were performed as described above.
In case of iron enhancement so called Perl’s reaction
was used in between the primary fixation of the samples
with aldehyde mixture and post-fixation with osmium.
The procedure was performed as described in Parmley
et al. [53].
Atomic spectrometry
Gallium standard solution (c = 1.000 mg/l) in the
highest quality available was purchased from Fluka
Chemie GmbH (Buchs, Switzerland). Total reflection
X-ray fluorescence analysis (TXRF) was carried out on
a S2-PICOFOX instrument (Bruker AXS, Berlin,
Germany) with an air-cooled molybdenum anode for
X-ray generation. The excitation settings were 50 kV and
750 mA and quartz glass disks were used as sample car-
riers. As internal standard, gallium with a concentration
of 10 mg/l was applied. Aliquots of the samples were
mixed with the same volume of the 10 mg/l gallium
standard solution, placed on the sample carriers and
evaporated to dryness. The analysis was performed by
signal integration over 1.000 seconds. For the determin-
ation, the peaks of iron (Kα1 = 6.3921 keV) and gallium
(Kα1 = 9.251 keV), as internal standard, were used.
Quantification was performed by the Bruker Spectra
software (version 6.1.5.0) and based on the known
concentration of the internal gallium standard.
Magnetic resonance imaging (MRI)
Images were acquired at 9.4 T on a Bruker BioSpec
94/20 (Ettlingen, Germany).
In vivo measurements
The subcutaneous lesions of infected mice were mea-
sured with a 1 T/m gradient system and a 35 mm vol-
ume coil using FLASH and UTE sequences with the
following parameters (FLASH: TR: 1,500 ms, TE: 6 ms,
FA: 30°, FOV: 3.20 × 3.20 cm, MTX: 256 × 256; UTE:
TR: 100 ms, TE: 314 μs, FA: 20 deg, FOV: 3.20 × 3.20 cm,
MTX: 256 × 256). For lymph node imaging a 0.7 T/m
gradient system and a surface coil was used and images
were acquired by a TurboRARE sequence (TR: 4.5 ms, TE:
9.3 μs, FOV: 4.50 × 2.50 cm, MTX: 512 × 312).
In vitro measurements
A total of 500 μl of iron-labeled S. aureus suspensions in
a concentration of OD 0.5 were washed with PBS and
suspended in 500 μl of a 0.5% agarose solution. T1 and
T2 measurements were performed using a 0.7 T/m gra-
dient system and a 72 mm volume coil by using the fol-
lowing pulse sequences: RAREVTR: TE: 10 ms, 30 ms,
50 ms, 70 ms, 90 ms, 110 ms, 130 ms; TR: 5,500 ms,
3,000 ms, 1,500 ms, 800 ms, 400 ms, 200 ms; average: 1;slice thickness: 1.5 mm; MTX: 128 × 128; RARE factor:
2; FOV: 23 mm × 40 mm. MSME: TE: 11 ms, 22 ms, 33
ms, 44 ms, 55 ms, 66 ms, 77 ms, 88 ms, 99 ms, 110 ms,
121 ms, 132 ms, 143 ms, 154 ms, 165 ms, 176 ms, 187
ms, 198 ms, 209 ms, 220 ms, 231 ms, 242 ms, 253 ms,
264 ms, 275 ms, 286 ms, 297 ms, 308 ms, 319 ms, 330
ms; TR: 2,500 ms; average: 1; slice thickness: 1.5 mm;
MTX: 256 × 256; FOV: 23 mm × 40 mm.Mice
Female C57BL/6 wild-type mice 8- to 12-weeks old were
purchased from Harlan-Winkelmann (Borchen,
Germany) and kept one week at the animal facility of
the Translational Research Imaging Center, Muenster,
Germany, before the beginning of the experiments. All
animal studies were performed with the approval of the
State Review Board of North Rhine-Westphalia,
Germany (TVA-Nr. 87–51.04.2001.A003, TVA-Nr. 8.87-
50.10.36.08.194).Animal models
Subcutaneous infection
The infection was induced in the left flank of C57BL/6
mice by subcutaneous injection of 100 μl of either iron-
labeled or unlabeled S. aureus suspensions (1 × 108
CFU/ml in PBS). N = 6 mice were used to assess the
fraction of iron-labeled bacteria 24 h post infection.Systemic lymph node infection
Mice were inoculated subcutaneously with 2 × 107 CFU
of iron-labeled or unlabeled S. aureus bacteria, by
injecting 50 μl of the cell suspensions (4 × 108 cells/ml
in PBS) into the left hind footpad as described previously
by Nippe et al. [47]. Control animals injected with the
same amount of PBS or PBS-based iron suspension
showed no significant swelling reaction. For each group
of infected mice four or five mice were used. Footpad
swelling was measured daily with a micrometric caliper,
and specific footpad swelling was assessed by subtracting
the diameter of injected (left) from non-injected (right)
footpad. Lymph node swelling and bacterial distribution
was observed by MRI. Mice were sacrificed by CO2
asphyxiation after the MRI measurements and lymph
nodes were either used for histology, electron micros-
copy or CFU counts. Colonies were counted after incu-
bation of homogenized tissue overnight at 37°C.Macrophage detection
Two hours and five hours post infection, mice were
injected i.v. with 100 μl of 5-nm IONP (VSOP,
Ferropharm AG, Teltow, Germany) suspensions (300
μmol/kg body weight).
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Additional file 1: Fluorescence microscopy of labeled S. aureus
bacteria. S. aureus labeled with Syto 9 (green) and rhodamine-coated
iron oxide particles (red). (A) screenMAG 100 nm polysaccharide, (B)
screenMAG 100 nm diethylamine ethyl, (C) screenMAG 100 nm
phosphatidyl-cholin, (D) screenMAG 100 nm poly(maleic acid-co-olefin).
Additional file 2: Fluorescence microscopy of labeled E. coli bacteria.
E. coli labeled with Syto 9 (green) and rhodamine-coated iron oxide
particles (red) by using either (A) amine-coated 5-nm IONPs or (B) citrate-
coated 5-nm IONPs.
Additional file 3: Murine macrophages phagocytizing iron-labeled
bacteria. The movie shows how iron-labeled S. aureus bacteria (red) are
phagocytized by murine macrophages.
Additional file 4: Longitudinal and transverse relaxation times of iron-
labeled S. aureus cultures, measured at different growth stages. The
measurements of the relaxivities showed that T1 did not change
significantly over the time course, while T2 was significantly decreased at
the beginning of the growth curve and increased steadily until a
stationary value was reached after 3 h.
Additional file 5: MR images of the left footpad injectedwith IONPs. (A)
IONPs in the footpad were observed as hypointensities (yellow arrow) in
axial T2*-weighted MRI. (B) T2-weighted images of the popliteal lymph
node on Day 2 post injection did not show hypointensities as was
observed for a footpad infection induced by iron-labeled bacteria.
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